Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
OCRA Rivkin Family SummeRun Raises $320K+ for Ovarian Cancer Research
More than 900 participants gathered at Seattle’s Seward Park on July 13, 2025, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. Now in its 32nd year, the beloved … Continued
How One Ovarian Cancer Survivor Turned Her Diagnosis Into a Mission to Save Lives | Heroes Highlights
As a 16-year survivor of primary peritoneal cancer who is continuously in treatment, author Jane Rubin has advice for anyone who has recently received a cancer diagnosis. “Let yourself react — it is crummy … Continued
Mercer Island Reporter Spotlights OCRA Rivkin Family SummeRun and Ovarian Cancer Research Impact
In a recent article, Mercer Island Reporter journalist Andy Nystrom looks at the history and ongoing impact of the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, the iconic annual … Continued